Post COVID Vaccination Experience among the United Arab Emirates General Public

Subject Areas : Journal of Chemical Health Risks

Tasnim Alomar ¹ , Mirza Rafi Baig ² , Hanan S. Anbar ³

1 - Department of Clinical Pharmacy and Pharmacotherapeutics, Dubai Pharmacy College for Girls, Dubai, 19099, United Arab Emirates
2 - Department of Clinical Pharmacy and Pharmacotherapeutics, Dubai Pharmacy College for Girls, Dubai, 19099, United Arab Emirates
3 - Department of Clinical Pharmacy and Pharmacotherapeutics, Dubai Pharmacy College for Girls, Dubai, 19099, United Arab Emirates

Received: 2023-11-16 Accepted : 2024-01-31 Published : 2024-03-16

Keywords: Vaccine, Experience, United Arab Emirates, COVID-19,

Abstract :

The study aimed to investigate the experience of the general public in the United Arab Emirates post-COVID-19 vaccines in order to find out the long-term side effects of COVID-19 vaccines. A cross-sectional survey was conducted among a sample of vaccinated individuals in the United Arab Emirates. A total of 500 respondents completed the survey. Twenty participants (4.7%) expressed concerns about either registering or receiving the COVID-19 vaccination, mainly due to their uncertainty about vaccine safety. 58.8% of the participants who have received Pfizer vaccine have received Sinopharm, Pfizer, or both vaccines together. Of them, 78.6% had experienced vaccine-related side effects. The most common side effects are pain/swelling at the injection site, muscle pain, tiredness, fever, headache, shivering, feeling unwell, and joint pain. Similarly, only 5.4% reported health problems after vaccination while 94.6% did not have any after vaccination. In the same way, only 3.6% developed a new disease after the COVID-19 vaccine. Additionally, 3% reported having contacts who experienced health problems/new diseases after vaccination. Overall, attitudes toward the COVID-19 vaccine were positive. Several differences in the incidence and number of vaccine-related adverse events experienced were due to age, sex, and vaccine type.

References:

1. Al-Hosani F., Al-Mazrouei S., Al-Memari S., Al-Yafei Z., Paulo M. S., Koornneef E., 2021. A review of COVID-19 mass testing in the United Arab Emirates. Frontiers in Public Health. 9, 661134-661140.


2. Berry D.A., Berry S., Hale P., Isakov L., Lo A.W., Siah K.W., Wong C.H., 2020. A cost/benefit analysis of clinical trial designs for COVID-19 vaccine candidates. PloS one. 15(12), e0244418- e0244425.


3. Tan C.M., Owuamalam C.K., Sarma V., 2022. Improving vaccination intent among skeptics through confidence in governments' handling of the COVID-19 pandemic. Acta Psychologica. 225,1-9.


4. Saddik B., Al-Bluwi N., Shukla A., Barqawi H., Alsayed H.A.H., Sharif-Askari N.S., Temsah M.H., Bendardaf R., Hamid Q., Halwani R., 2022. Determinants of healthcare workers perceptions, acceptance and choice of COVID-19 vaccines: a cross-sectional study from the United Arab Emirates. Human Vaccines & Immunotherapeutics. 18(1), 1-9.


5. Ahamed F., Ganesan S., James A., Zaher W.A., 2021. Understanding perception and acceptance of Sinopharm vaccine and vaccination against COVID–19 in the UAE. BMC Public Health. 21, 1-11.


6. Shekhar R., Sheikh A.B., Upadhyay S., Singh M., Kottewar S., Mir H., Barrett E., Pal S., 2021. COVID-19 vaccine acceptance among health care workers in the United States. Vaccines. 9(2), 119-126.


7. Chew N. W., Cheong C., Kong G., Phua K., Ngiam J.N., Tan B.Y., Wang B., Hao F., Tan W., Han X., 2021. An Asia-Pacific study on healthcare workers’ perceptions of, and willingness to receive, the COVID-19 vaccination. International Journal of Infectious Diseases. 106, 52-60.


8. Qunaibi E., Basheti I., Soudy M., Sultan I., 2021. Hesitancy of Arab healthcare workers towards COVID-19 vaccination: a large-scale multinational study. Vaccines. 9(5), 446-452.


9. Ogilvie G.S., Gordon S., Smith L.W., Albert A., Racey C.S., Booth A., Gottschlich A., Goldfarb D., Murray M. C., Galea L. A., 2021. Intention to receive a COVID-19 vaccine: results from a population-based survey in Canada. BMC Public Health. 21(1), 1017-1022.


10. Hatmal M.M.M., Al-Hatamleh M.A., Olaimat A.N., Hatmal M., Alhaj-Qasem D.M., Olaimat T.M., Mohamud R., 2021. Side effects and perceptions following COVID-19 vaccination in Jordan: a randomized, cross-sectional study implementing machine learning for predicting severity of side effects. Vaccines. 9(6), 556-563.


11. Andrzejczak-Grzadko S., Czudy Z., Donderska M., 2021. Side effects after COVID-19 vaccinations among residents of Poland. Eur Rev Med Pharmacol Sci. 4418-4421.


12. Almalki O.S., Santali E.Y., Alhothali A.A., Ewis A.A., Shady A., Fathelrahman A.I., Abdelwahab S.F., 2023. The role of blood groups, vaccine type and gender in predicting the severity of side effects among university students receiving COVID-19 vaccines. BMC Infectious Diseases. 23(1), 1-11.


13. Beatty A.L., Peyser N.D., Butcher X.E., Cocohoba J.M., Lin F., Olgin J.E., Pletcher M.J., Marcus G.M., 2021. Analysis of COVID-19 vaccine type and adverse effects following vaccination. JAMA Network Open. 4(12), e2140364-e2140364.


14. Babaee E., Amirkafi A., Tehrani-Banihashemi A., SoleimanvandiAzar N., Eshrati B., Rampisheh Z., Asadi-Aliabadi M., Nojomi M., 2022. Adverse effects following COVID-19 vaccination in Iran. BMC Infectious Diseases. 22(1), 1-8.


15. Al Khames Aga Q.A., Alkhaffaf W.H., Hatem T.H., Nassir K.F., Batineh Y., Dahham A.T., Shaban D., Al Khames Aga L. A., Agha M. Y., Traqchi M., 2021. Safety of COVID‐19 vaccines. Journal of Medical Virology. 93(12), 6588-6594.


16. Elnaem M.H., Mohd Taufek N.H., Ab Rahman N.S., Mohd Nazar N.I., Zin C.S., Nuffer W., Turner C.J., 2021. Covid-19 vaccination attitudes, perceptions, and side effect experiences in malaysia: Do age, gender, and vaccine type matter? Vaccines. 9(10), 1156-1165.


17. Mori M., Yokoyama A., Shichida A., Sasuga K., Maekawa T., Moriyama T., 2022. Impact of Sex and Age on mRNA COVID-19 Vaccine-Related Side Effects in Japan. Microbiology Spectrum. 10(6), e01309-01322.


18. Alemayehu A., Demissie A., Yusuf M., Abdullahi Y., Abdulwehab R., Oljira L., Feleke D., 2022. COVID-19 vaccine side effect: age and gender disparity in adverse effects following the first dose of AstraZeneca COVID-19 vaccine among the vaccinated population in Eastern Ethiopia: a community-based study. SAGE Open Medicine. 10, 1-8.


19. Tosun F., Bulbul M., Tosun İ., 2022. Comparison of severe acute respiratory syndrome coronavirus 2 (COVID-19) vaccine side effects by age groups. Revista da Associação Médica Brasileira. 68, 476-481.


20. Wang J., Tong Y., Li D., Li J., Li Y., 2021. The impact of age difference on the efficacy and safety of COVID-19 vaccines: a systematic review and meta-analysis. Frontiers in Immunology. 12, 1-7.


21. Lim S.M., Chan H.C., Santosa A., Quek S.C., Liu E.H.C., Somani J., 2021. Safety and side effect profile of Pfizer-BioNTech COVID-19 vaccination among healthcare workers: A tertiary hospital experience in Singapore. Ann Acad Med Singap. 50(9), 703-711.


22. Ruiz-Quiñones J.A., Narváez-Osorio V.M., Ulín-Tejeda O.A., Flores-Barrientos O.I., Suárez-Méndez S., del Carmen Baeza-Flores G., 2022. Side effects of the Pfizer BioNTech vaccine in health workers of a hospital in the southeast of Mexico. The Journal of Infection in Developing Countries. 16(09), 1413-1416.


23. Nguyen S.V., Nguyen B.T., Duong H.N.V., Lenh P.T., Tran K.T., Tran H.M., Nguyen T.C., Nguyen D.P., Ta M.N., Trieu N.N.M., 2023. Side effects following first dose of COVID-19 vaccination in Ho Chi Minh City, Vietnam. Human Vaccines & Immunotherapeutics. 19(1), 1-7.


24. Mohammedsaeed W., Alrashidi H., Alsharif S.M., Aljardi O., Al-Sehli A., Mohammed Saeed W., Alsharif S., 2023. COVID-19 Vaccine Impacts in Saudi Arabia: A Cross-Sectional Study. Cureus. 15(6) 1-9.


25. Riad A., Hocková B., Kantorová L., Slávik R., Spurná L., Stebel A., Havriľak M., Klugar M., 2021. Side effects of mRNA-based COVID-19 vaccine: nationwide phase IV study among healthcare workers in Slovakia. Pharmaceuticals. 14(9), 873-880.